Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Determining the risk of Cardiovascular Disease (CVD) is a necessity for timely preventive interventions in high-risk groups. However, laboratory testing may be impractical in countries with limited resources. This study aimed at comparison and assessment of the agreement between laboratory-based and non-laboratory-based WHO risk charts models.

Methods: This study was performed using the baseline data of 8138 participants in the pars cohort study who had no history of CVD and stroke. The updated 2019 WHO model was used to determine the 10-year fatal and non-fatal CVD risks. In general, there are two types of new WHO risk prediction models for CVD. The scores were determined based on age, sex, smoking status, diabetes, Systolic Blood Pressure (SBP), and total cholesterol for the laboratory-based model and age, sex, smoking status, SBP, and Body Mass Index (BMI) for the non-laboratory-based model. The agreement of these two models was determined via kappa statistics for the classified risk (low: < 10%, moderate: 10-< 20%, high: ≥ 20%). Correlation coefficients (r) and scatter plots was used for correlation between scores.

Results: The results revealed very strong correlation coefficients for all sex and age groups (r = 0.84 for males < 60 years old, 0.93 for males ≥ 60 years old, 0.85 for females < 60 years old, and 0.88 for females ≥ 60 years old). In the laboratory-based model, low, moderate, and high risks were 76.10%, 18.17%, and 5.73%, respectively. These measures were respectively obtained as 77.00%, 18.08%, and 4.92% in the non-laboratory-based model. Based on risk classification, the agreement was substantial for males < 60 years old and for both males and females aged ≥ 60 years (kappa values: 0.79 for males < 60 years old, 0.65 for males ≥ 60 years old, and 0.66 for females ≥ 60 years old) and moderate for females < 60 years old (kappa = 0.46).

Conclusions: The non-laboratory-based risk prediction model, which is simple, inexpensive, and non-invasive, classifies individuals almost identically to the laboratory-based model. Therefore, in countries with limited resources, these two models can be used interchangeably.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925162PMC
http://dx.doi.org/10.1186/s12967-022-03336-4DOI Listing

Publication Analysis

Top Keywords

laboratory-based non-laboratory-based
8
cardiovascular disease
8
risk charts
8
age sex
8
sex smoking
8
smoking status
8
risk
5
comparison laboratory-based
4
non-laboratory-based cardiovascular
4
disease risk
4

Similar Publications

Estimation of cardiovascular risk among adults using WHO cardiovascular disease (CVD) risk charts: A community-based cross-sectional study.

J Family Med Prim Care

July 2025

Department of Community Medicine, Ministry of Labour and Employment, Government of India, New Delhi, India.

Introduction: Cardiovascular diseases (CVDs) are the leading cause of death globally with three-fourths of the deaths occurring in low- and middle-income countries. According to the World Health Organization (WHO), CVDs represent 32% of the total global deaths that occurred in 2019, which is indeed a very high number.

Aim And Objectives: The aim of this study was to estimate the 10-year risk of cardiovascular events among adults aged ≥ 40 years in a rural population using the WHO CVD risk prediction charts for the South Asia region.

View Article and Find Full Text PDF

This study aimed to predict the likelihood of natural conception among couples by using a machine learning (ML) approach based on sociodemographic and sexual health data. This marks a novel, non-invasive methodology for fertility prediction. This prospective study included 197 couples divided into two groups: 98 fertile couples (Group 1) who achieved natural conception within one year, and 99 infertile couples (Group 2) who were unable to conceive despite regular unprotected intercourse.

View Article and Find Full Text PDF

Background: Current guidelines for atherosclerotic cardiovascular disease (ASCVD) primary prevention mostly recommend risk scores that predict risk of non-fatal myocardial infarction, fatal ischemic heart disease (IHD), and fatal or non-fatal ischemic stroke (hard outcomes), ignoring the burden from other non-fatal IHD outcomes. We explored the optimal risk thresholds for statin initiation using non-laboratory-based soft and hard ASCVD outcome models and compared the cost-utility of such models in the Chinese population.

Methods: We constructed Markov cohort models to estimate the incidence of ASCVD events, costs, and quality-adjusted life years (QALYs) over a lifetime from a social perspective.

View Article and Find Full Text PDF

Objective: We compared non-laboratory models' efficacy with standard laboratory-based model in identifying high-risk populations for cardiovascular disease (CVD) in resource-limited settings.

Methods: A national sample of 121 672 individuals aged 40-70 from the PERSIAN cohort was analyzed. Non-laboratory models, including the World Health Organization (WHO) and Iranian pooled-cohort CVD mortality models, were compared with the WHO laboratory-based model.

View Article and Find Full Text PDF

Background: The World Health Organization (WHO) non-laboratory cardiovascular disease (CVD) risk chart is sub-region-specific and is advocated in resource-constrained settings. However, the extent of agreement with laboratory-based assessment among hypertensive adults attending primary health centers (PHCs) in the West Africa sub-region remains unknown. This study compared 10-year CVD risk among adults with hypertension attending PHCs in Ghana and Nigeria.

View Article and Find Full Text PDF